If these bees could be trained, multiplied and cared for, the risk of honey collection would vanish. And the income would ...

Novartis has claimed a first-in-class regulatory approval in the US for oral BTK inhibitor remibrutinib as a second-line treatment for chronic spontaneous urticaria (CSU), also known as chronic hives.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new data highlighting the potential of ...

QuickBet has an Acca Boost promo mostly on top league football and basketball. They will pump your odds by up to 50% for accumulator betting wagers with at least 4 legs. Golden Boosts are offered on ...